- Home
- MIRM vs NICE Comparison
MIRM vs NICE Comparison
Compare MIRM & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | NICE |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | United States | Israel |
| Employees | N/A | 9626 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.4B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIRM | NICE |
|---|---|---|
| Price | $106.24 | $86.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $119.85 | ★ $153.46 |
| AVG Volume (30 Days) | 667.9K | ★ 700.8K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | $10.14 |
| Revenue Next Year | $22.04 | $9.62 |
| P/E Ratio | ★ N/A | $11.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.89 | $89.03 |
| 52 Week High | $112.00 | $180.61 |
Technical Indicators
Market Signals| Indicator | MIRM | NICE |
|---|---|---|
| Relative Strength Index (RSI) | 62.25 | 34.43 |
| Support Level | $87.26 | N/A |
| Resistance Level | $107.51 | $114.76 |
| Average True Range (ATR) | 5.87 | 4.70 |
| MACD | 0.98 | -1.78 |
| Stochastic Oscillator | 75.13 | 0.32 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About NICE NICE Ltd
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.